19 results on '"Guan, X."'
Search Results
2. SA82 A Bayesian Network Meta-Analysis of the Tyrosine Kinase Inhibitors (TKI) for ALK-Positive Advanced Non-Small Cell Lung Cancer With or Without Brain Metastasis
3. EE197 Cost-Effectiveness Analysis of Trastuzumab Emtansine Versus Pertuzumab with Trastuzumab for Chinese Patients with Residual Invasive HER2-Positive Early Breast Cancer
4. RWD160 An Episode-Based Analysis in a Medicare Advantage Population to Identify the Cost Impact of Virtual-First Care for Common Acute Conditions
5. HSD44 Association of Penicillin Allergy Documentation and First-Line Penicillin Prescribing for Common Infections in Primary Healthcare Facilities in Beijing
6. PND30 COST-UTILITY ANALYSIS OF HUMAN URINARY KALLINDINOGENASE VERSUS 3-N-BUTYLPHTHALIDE FOR PATIENTS WITH MILD OR MODERATE ACUTE ISCHEMIC STROKE
7. PCN79 AN ECONOMIC EVALUATION OF NIVOLUMAB COMPARED WITH DOCETAXEL AS THE SECOND-LINE TREATMENT FOR PATIENTS WITH ADVANCED NSCLC IN CHINA USING MARKOV MODEL AND PARTITIONED SURVIVAL MODEL
8. PND112 REAL WORLD HEALTH UTILITY SCORES OF PATIENTS WITH ACUTE ISCHEMIC STROKE MEASURED USING EQ-5D-3L IN CHINA
9. PCN230 COST-EFFECTIVENESS ANALYSIS OF PERTUZUMAB WITH TRASTUZUMAB AND CHEMOTHERAPY COMPARED TO TRASTUZUMAB AND CHEMOTHERAPY IN THE NEOADJUVANT TREATMENT OF HER2-POSITIVE EARLY OR LOCALLY ADVANCED BREAST CANCER IN CHINA
10. CC4 COST-EFFECTIVENESS ANALYSIS OF PERTUZUMAB WITH TRASTUZUMAB AND CHEMOTHERAPY COMPARED TO TRASTUZUMAB AND CHEMOTHERAPY IN THE ADJUVANT TREATMENT FOR PATIENTS WITH HER2-POSITIVE EARLY BREAST CANCER AT HIGH RISK OF RECURRENCE IN CHINA
11. PNS64 DOES IT WORTH TO INVEST ON INTRAOPERATIVE HYPOTHERMIA PREVENTION? - HYBRID EVIDENCES FROM META-ANALYSES AND COST-BENEFIT ANALYSIS
12. Clinical Efficacy And Costs Of Insulin Analogue Compared To Human Insulin In Patients With Diabetes: Results From A Tertiary Hospital In Beijing
13. Anti-Diabetic Drug Utilization And Dynamic Trends In A Tertiary Hospital In Beijing (2008-2012)
14. PDB5 GLYCAEMIC AND WEIGHT EFFECTS OF EXENATIDE FOR DIFFERENT AGE GROUPS
15. PDB30 - Anti-Diabetic Drug Utilization And Dynamic Trends In A Tertiary Hospital In Beijing (2008-2012)
16. PDB21 - Clinical Efficacy And Costs Of Insulin Analogue Compared To Human Insulin In Patients With Diabetes: Results From A Tertiary Hospital In Beijing
17. PDB21 Clinical Efficacy And Costs Of Insulin Analogue Compared To Human Insulin In Patients With Diabetes: Results From A Tertiary Hospital In Beijing
18. Patient-Reported Frequency and Burden of Hypoglycaemia for Insulin-Treated Diabetes Patients In 5 Cities of China: A Cross-Section Study.
19. Patient-Reported Medical Expenditures For Insulin-Treated Diabetes Patients In Eastern, Central And Western Regions Of China.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.